Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pain × Acetaminophen × Clear all

Phase

Status

Completed 7 Unknown 2 Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Trigger Finger Disorder 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Mesothelioma 1 Median Neuropathy 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia 1 Head and Neck Neoplasms 1 Ganglion Cysts 1 Emergence Delirium 1 Delirium 1 De Quervain Disease 1 Carcinoma 1 Burkitt Lymphoma 1

Interventions

Morphine 5 Methadone 4 Fentanyl 4 Zoledronic Acid 3 Tapentadol 2 Radiotherapy 2 Pregabalin 2 Prednisone 2 Ketamine 2 Ibandronic Acid 2 Hydromorphone 2 Glutamine 2 Acupuncture Therapy 2 pegfilgrastim 1 oxycodone naloxone combination 1 naloxegol 1 ixabepilone 1 incobotulinumtoxinA 1 imisopasem manganese 1 cyclobenzaprine 1 cabozantinib 1 acetaminophen, aspirin, caffeine drug combination 1 Zolpidem 1 Surveys and Questionnaires 1 Sugars 1 Standard of Care 1 Soybean Proteins 1 Sodium Bicarbonate 1 Ropivacaine 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02706769 2019-09-27

PaSO

University of Edinburgh

Phase NA Terminated

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡